Financials
Financial year 2025
Gross margin
€ -1 million
Profit
Caution€ -2.7 million
Debts
Low€ 1.3 million
SPICA THERAPEUTICS from Antwerpen, company number BE1012800853, closed financial year 2025 with a result of € -2.7 million after tax. For that financial year SPICA THERAPEUTICS recorded a gross margin of € -1 million and equity of € 6.2 million. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 21, 2026.
What happened at SPICA THERAPEUTICS?
What happened at SPICA THERAPEUTICS in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Debora Dumont Management Company CommV stepped down as director. NBB
- Participatiemaatschappij Vlaanderen NV stepped down as director. NBB
- bioskills BV stepped down as director. NBB
- TRIANGULATE GmbH Buitenlandse entiteit stepped down as director. NBB
- QBIC VENTURE PARTNERS III NV stepped down as director. NBB
- Impala Consulting CommV stepped down as director. NBB
- New annual accounts for financial year 2025: loss of € 2.7 million. Source: NBB ↗
- Debora Dumont Management Company CommV became a director. NBB
A new publication or filing at SPICA THERAPEUTICS? We notify you, reason included.
Follow SPICA THERAPEUTICSNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
It owns 100% of OncoSpear ApS itself.
Directors
According to the 2025 annual accounts
Debora Dumont Management Company CommV
Director · represented by Debora Dumont
Also active at: BIOQUBE VENTURES, BQV Partners
since 2025 · until 2031
Participatiemaatschappij Vlaanderen NV
Director · represented by Bart De Taeye
Also active at: VLAAMSE INSTELLING VOOR TECHNOLOGISCH ONDERZOEK, Arts Gebroeders immobilière, BEDRIJVENCENTRUM VILVOORDE +141 more
since 2025 · until 2031
since 2025 · until 2031
TRIANGULATE GmbH Buitenlandse entiteit
Director · represented by James Rush
since 2025 · until 2031
Director · represented by Steven Leuridan
Also active at: RheaVita, VoxelSensors, AnimAb +7 more
since 2025 · until 2031
Director · represented by Alexander Demoulin
since 2025 · until 2031
Establishments
Establishment units
Physical locations of this company
Uitbreidingstraat 66 box 3
2600 Antwerpen
Uitbreidingstraat 66 box 31
2600 Antwerpen
Active since 26 August 2024
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 84 companies are registered at this address.
VTG Rail Logistics Belgium
€ 729 gross margin · 2026
LOGWIN AIR + OCEAN BELGIUM
€ 1.5 million gross margin · 2025
KIWI'S
€ 133,528 gross margin · 2025
C & Q-INVEST
€ -91,038 gross margin · 2024
ANGLO - BELGE SPECIAL RISKS
€ 495,943 gross margin · 2025
+79 more
Details
- Company number
- 1012.800.853
- VAT number
- BE 1012.800.853
- Registered office
- Uitbreidingstraat 66 bus 3, 2600 Antwerpen
- Names & denominations
- SPICA THERAPEUTICS
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 26 August 2024
- Peppol
- Active · Active since 25 Nov 2024
- Activities · NACE
Speur- en ontwikkelingswerk op biotechnologisch gebied
Vervaardiging van overige farmaceutische producten
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Vervaardiging van geneesmiddelen
Vervaardiging van farmaceutische grondstoffen
Overige gespecialiseerde wetenschappelijke en technische activiteiten